North Syracuse, NY, United States of America

Stephen G Zegarelli

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2008-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen G Zegarelli. Retrieved from https://idiyas.com/inventor/stephen-g-zegarelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0



Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 124(Granted Patents)


Company Filing History:


Years Active: 2008-2009

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Stephen G. Zegarelli in Protein Production

Introduction

Stephen G. Zegarelli, an accomplished inventor based in North Syracuse, NY, has made notable contributions in the field of protein production through mammalian cell culture processes. With a total of two patents to his name, Zegarelli's work focuses on enhancing the quality and yield of glycoproteins, which are critical in various biopharmaceutical applications.

Latest Patents

Zegarelli's latest patents emphasize innovative methods and processes for producing proteins, specifically glycoproteins, using animal or mammalian cell cultures. One of his patents details a two-temperature shift technique that enhances cell viability throughout the culturing process, resulting in a higher end titer of quality protein products. Additionally, the introduction of polyanionic compounds at strategic points during the culturing period further optimizes cell growth and prolongs the production phase.

Another significant patent describes the use of D-galactose in feed mediums to improve the sialylation of the produced proteins. This method involves maintaining effective levels of D-galactose throughout the culture's duration, thereby reversing the decline in sialylation often observed during scale-up processes. Such advancements are beneficial for large-scale protein production, ensuring efficiency and product quality.

Career Highlights

Zegarelli is associated with the renowned Bristol-Myers Squibb Company, where he has been instrumental in advancing cellular processes related to protein production. His work in this area not only enhances the effectiveness of biopharmaceuticals but also contributes to the broader scientific understanding of mammalian cell cultures.

Collaborations

Throughout his career, Zegarelli has collaborated with fellow researchers, including Bernhard M. Schilling and Linda Matlock. These collaborations reflect a commitment to innovation and excellence in the field of biotechnology, underscoring the importance of teamwork in achieving significant scientific breakthroughs.

Conclusion

Stephen G. Zegarelli's contributions to the field of protein production through innovative mammalian cell culture processes demonstrate the impact of inventive thinking in biotechnology. His patents pave the way for higher quality and more efficient protein products, benefiting both the scientific community and the biotechnology industry at large.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…